Lilly has secured exclusive rights to use Ascidian’s RNA exon‑editing platform for new kidney disease treatments. The system can fix faulty genes without permanently changing a patient’s DNA, offering an alternative to traditional CRISPR methods. The deal gives Ascidian up to $1. 9 billion, split
A famous actor left a big film in December 2025, sparking one of the biggest disputes in Indian cinema. The fight involves a popular production company and about 25 top industry leaders, leading to an audit by a major accounting firm and a directive from a workers’ federation. The core of the dis
Angola’s Lisima plateau, a rarely explored highland that feeds major African rivers, has become the focus of an exciting new biological survey. Scientists and explorers from Africa and abroad trekked into this isolated area, overcoming muddy roads, broken equipment and the lingering danger of malari
Disney parks have always mixed technology with entertainment—think animatronic singers and gravity-defying roller coasters. Now, a marble-carving robot is joining the team. Unlike the flashy rides guests remember, this robot works quietly in the background. It roughs out large statues from big block
Federal agencies have suddenly blocked nearly twenty-one million dollars in science grants at the University of California, Berkeley. The reason given? Some researchers did not tell the government about outside money they received, mostly from friendly countries like the United Kingdom, Australia, a
People who have intellectual disabilities often struggle with vision problems, yet getting an eye exam can be hard. Families of those who have never gone to an eye doctor say that the main obstacles are cost, lack of transportation, and a shortage of doctors who understand their needs. Those fami
The story starts with a man who loved movies. He made small films that got people talking. Then he released a space adventure in 1977 that everyone watched. That film became the biggest hit of its time. The studio that made the film was not sure it would work. They were scared to spend too much mon
Artists sometimes turn into lightning rods for opinions that fans didn’t sign up to hear. During one stop of Kid Cudi’s Rebel Rangers Tour in Dallas, singer M. I. A. decided to share her political views with the crowd. She mentioned endorsing Donald Trump in 2024 and called herself a Republican vote
A small biotech company is getting a big boost from artificial intelligence in its search for cancer treatments. Instead of relying only on lab tests and guesswork, the firm is using AI to speed up how it designs and picks new drug candidates. This approach isn’t just a small tweak—it’s reshaping ho
A Chinese company is building AI systems that track people’s behavior to guess who might criticize the government later. Internal documents reviewed by a university team show Geedge Networks combines phone location, internet use, and movement data to create "future behavior" profiles. Instead of jus
